Bonti Announces Results of Phase 2a Scar Reduction Clinical Study
Bonti, a privately held, clinical-stage biotechnology company, announced topline results of its SHINE-1 (Scar Healing Improvement with Neurotoxin E) Phase 2a clinical trial, which evaluated the company's EB-001A for scar reduction following Mohs surgery. EB-001, the active ingredient in EB-001A, is a novel botulinum neurotoxin serotype E with a unique clinical profile, characterized by a faster onset of action and a shorter duration of activity compared to botulinum neurotoxin serotype A products.
For the randomized, placebo-controlled, double-blind trial, EB-001A or placebo was administered to the frontalis muscle immediately after Mohs surgery for skin lesions in the forehead in 12 subjects. Subjects were followed up to 90 days post-treatment. Per the company's release, EB-001A was well tolerated with no drug-related adverse events. It appeared to provide maximum benefit during the acute scar formation phase as the...
The last Posts from "Surgical Aesthetics Magazine"
- Alma acquires Medical Nova
- Galderma Launches Joint Promotions With Top Skincare Brands
- New Study Confirms Pathophysiology of Filler-Induced Blindness
- Coffee Intake Reduces Risk of Rosacea
- Profile: Urmen Desai, MD
- Merz Launches new XEOMIN “Later Haters” Campaign
- 2019 NRS Rosacea Research Grants Available
- Revance Releases Phase 3 Study Results for Toxin RT002
- Allergan Announces New Finance Leadership Team Members
- NeoGraft Launches Technician Scheduling App For Physician Partners
- Vbeam Prima PDL For Poikiloderma of Civatte
- Researchers Regrow Hair on Wounded Skin
- PRP For Facial Rejuvenation
- FDA Announces First Steps in Medical Device Approval Overhaul
- Legal Issues: Physicians Gifts
- Practice Marketing: Virtual Events
- Restylane Lyft Approved for Midface Injection via Cannula
- Phase 3 Data on CCH for Cellulite
- U.S. Tops Demand For Cosmetic Procedures
- Rules of Engagement: Patient Privacy
The headlines of Master Doctor
Obamacare Will 'Likely' Survive Judge's Ruling, Obama Tweets
He reassures Americans as he reminds people to sign up for the health care program before the deadline.
Study: PQQ may prevent and even reverse Alzheimer's
Alzheimer's disease may be one of the most fearsome health conditions common among the elderly. Imagine gradually losing your memory while your body weakens. But the risk of...
Priest Torments Mourners By Condemning Teen's Death By Suicide At His Funeral
During 18-year-old Maison Hullibarger's funeral, a priest criticized him for dying by suicide When Jeff and Linda Hullibarger met with Father LaCuesta ahead of their son's...
Early Physical Therapy Reduces Risk of Opioid Use
For patients with shoulder, back or knee pain who did use opioids, early physical therapy was associated with a 5 to 10 percent reduction in how much of the drug they used, the...
Most Accurate Tool Yet to Predict Asthma in Kids: Study
Pediatric Asthma Risk Score will become the most common tool used to predict asthma in young children and help prevent the common airway disease from developing, reveals a new...
How Allergies in Infants are Impacted by Diet During Pregnancy?
In a longitudinal study of pregnant women across US, many of the women avoided certain allergenic foods to prevent food allergies in infants.
BREAKING: Obamacare ruled unconstitutional by federal judge. era of forced...
In a stunning ruling that's sending shock waves across the nation, a federal judge has ruled that Obamacare - the deceptively named “Affordable Care Act” - violates the United...
4 Good reasons why you should give fermented foods a try
If you're new to fermented foods, you may have a hard time eating them, especially since some dishes can look and smell strange. However, if you give fermented foods a chance...
New study explains why having a lower calorie intake is healthier for you
A study from the University of Geneva backs the age-old knowledge that losing weight requires reducing your caloric intake. However, the researchers say it's not so your body...
Johnson & Johnson knew for DECADES that asbestos lurked in its baby powder...
A Reuters investigation said the papers, dating from 1971 to the 2000s, show J&J knew that the powders sometimes tested positive for asbestos. The firm closed out down 10...